4,937 research outputs found
Interview with Douglas Jackson
No full textDouglas Jackson is the author of Timberwolf Goes to War, an autobiography of his wartime experience. He entered United States Army service in October of 1942, and served in the 104th Infantry Division, 413th Regiment, during World War II. Here, he discusses his experience as an American soldier in Germany during WWII
The geology and scenery of Sutherland
No full textby Henry M. CadellHandschriftliches Exlibris: "Dr. Alb. Heim" Exemplar der ETH-BIB, Rar 46804Exlibrisstempel: "Geolog. Institut der Eidg. techn. Hochschule Bibliothek Schenkung Heim" 002323356_0004 Exemplar der ETH-BIBHandschriftliches Geschenkexlibris: "From the Author 9.IX.1912" Exemplar der ETH-BIB, Rar 4680
Mrs. Helen Douglas Morton Obituary
No full textNewspaper Article - Mrs. Helen Douglas Morton ObituaryAlberta Women's Institutes; AWI CollectionDeaths
MORTON— On Sat.. Oct. 17. Mrs.
Helen Douglas Morton of Vegreville.
passed away at the age of 68 years.
She is survived by 2 sons.' Edmund
Forrest of Vegreville and Alexander
Charles of Calgary, also 2 grandchildren.
Her husband predeceased her
by 8 months.
Funeral service will be held on
Wed. Oct. 21 at 2: 00 p. m. at the
Vegreville United Church. Rev. G.
B. Mather will officiate and interment
will be made in the family
plot. Riverside Cemetery. No flowers
by request. Donations to the Canadian
Cancer Society or the Canadian
National Institute for the Blind will
be gratefully accepted. Park Memorial
Ltd.. ( Vegreville) Funeral Administrators
and Directors. The Chapel on
the Boulevard
Author, Actor and Audience- Figures: The Theatrical Metaphor in Jonsonian Comedy
No full textIn this thesis, I am concerned with Jonson's attitude toward theatricality in the world. His representation of a "centered self," especially in his poems, can be seen both as a part of the Renaissance concern with fashioning identity and as a protest against the theatrical role-playing it often caused. I am further interested in Jonson's conception of the nature of the theatre as a significant social activity. He employs the theatrical metaphor in Volpone, Epicoene, and The Alchemist in which clever author and actor-figures deceive less clever audience-figures who lack proper judgement. These characters reflect Jonson's awareness of his own engagement with his audience. The series of plays-within-the-play illustrate a theatre of deception and manipulation by which Jonson comes to measure both himself as a playwright and his art. This study also attempts to come to terms with the interesting discrepancy between Jonson the moralist and Jonson the artist. There is a certain tension created in Jonsonian comedy when we consider that he infuses his theatrical tricksters with immense comic vigour. The audience's ability to pass judgement on the author and actor-figures' subversive actions is complicated since they perform so amusingly and with such brilliance. As well, I trace the development of Jonson's thinking about the nature and function of comedy. With each successive play, I find that he subtly disguises his moral idealism in order to write successful comedy. A problem with this formula was that it tended to mask Jonson's identity as a morally purposeful writer. Increasingly, his comedies seemed to owe their success to a triumph of theatrical over moral values. Jonson remains a morally responsible dramatist who incorporates into his art the critical acceptance of the stage as a medium.Master of Arts (MA
Illiquidity and Interest Rate Policy
No full textThe cheapest way for banks to finance long term illiquid projects is typically to borrow short term from households. But when household needs for funds are high, interest rates will rise sharply, debtors will have to shut down illiquid projects, and in extremis, will face more damaging runs. Authorities may want to push down interest rates to maintain economic activity in the face of such illiquidity, but intervention may not always be feasible, and when feasible, could encourage banks to increase leverage or fund even more illiquid projects up front. This could make all parties worse off. Authorities may want to commit to a specific policy of interest rate intervention to restore appropriate incentives. For instance, to offset incentives for banks to make more illiquid loans, authorities may have to commit to raising rates when low, to counter the distortions created by lowering them when high. We draw implications for interest rate policy to combat illiquidity.
Breathing during sleep
No full textThis thesis reports studies on the cause, associations, diagnosis and treatment of breathing
problems during sleep. The development of an accurate oximeter in the late 1970s allowed,
for the first time, continuous measurement of oxygenation during sleep. Studies in patients
with chronic obstructive pulmonary disease(COPD) demonstrated they became markedly
hypoxaemic and hypoventilated during Rapid Eye Movement (REM) sleep. These episodes
were associated with pulmonary hypertension and with raised erythropoetin and probably
contribute to the development of cor pulmonale and secondary polycythemia. Subsequent
studies showed no clinical value in performing overnight studies of breathing and oxygenation
in routine practice. Having proved that patients with COPD had the same breathing pattern
during sleep as normals, studies in normal subjects showed that ventilation and ventilatory
responses to hypoxia and hypercapnia were decreased during sleep, most markedly during
REM sleep. Modelling studies suggested hypoventilation could explain the sleep hypoxaemia
in COPD.Studies in patients with asthma confirmed nocturnal symptoms were common and related to a
sleep controlled circadian variation in airway calibre, at least partly due to variations in
parasympathetic and non-adrenergic, non-cholinergic bronchomotor tone. It was also shown
that changes in posture and in airway inflammation were not key to nocturnal asthma, and that
consequences of nocturnal asthma included sleep disruption and cognitive impairment. Longacting inhaled (12 agonists were shown to improve asthma control and sleep quality.
Having confirmed and extended the clinical features of the obstructive sleep
apnoea/hypopnoea syndrome (OSAHS), studies were then performed to help clarify cause,
associations, diagnosis and treatment of OSAHS. These identified a familial trait even in thin
OSAHS patients and associated this with jaw shortening, and also identified gender, age and
obesity related differences in upper airway structure and function. They also showed the
importance of episodes of marked hypoventilation - hypopnoeas - in causing the syndrome,
identified the neurocognitive consequences of OSAHS and showed that OSAHS was
associated with elevation of blood pressure. They established that the symptoms and
cognitive defects of OSAHS can be reproduced by repeated awakenings of normal subjects
with sounds, and that even sounds which do not produce classical EEG arousals can produce
sleepiness. Our investigations have also challenged the need to perform classical
polysomnography to diagnose OSAHS, and helped establish that home sleep studies can be
diagnostic in many patients, and are cost-effective. A series of randomised controlled trials of
the CPAP therapy have provided a firm evidence base for the treatment of OSAHS. These
have shown clear benefits from CPAP in terms of symptoms, sleep quality, objective
sleepiness, cognition, quality of life, mood and blood pressure in symptomatic patients with
>15 apnoeas + hypopnoeas/hr slept. In symptomatic patients with 5-15 apnoeas +
hypopnoeas/hr slept there were definite benefits in symptoms, quality of life, mood and some
areas of cognition but no change in objective sleepiness. These studies have been key to the
current North American definitions of OSAHS. Studies also showed no benefit from treating
asymptomatic individuals with >30 apnoeas + hypopnoeas/hr slept with CPAP. Our
investigations have highlighted the need to monitor CPAP use, and shown that longterm
CPAP use is >90% in sleepy patients with severe OSAHS. However milder patients use
CPAP less well longterm, highlighting the need for effective alternative therapies.1. Douglas NJ, Brash HM, Wraith PK, Calverley PM, Leggett RJ, McElderry L et al.
Accuracy sensitivity to carboxyhemoglobin, and speed of response of the HewlettPackard 47201A ear oximeter. Am.Rev.Respir.Dis. 1979;119:311-3. •
2. Douglas NJ, Calverley PM, Leggett RJ, Brash HM , Flenley DC, Brezinova V.
Transient hypoxaemia during sleep in chronic bronchitis and emphysema. Lancet
1979;1:1-4. •
3. Catterall JR, Douglas NJ, Calverley PM, Shapiro CM, Brezinova V, Brash HM et al.
Transient hypoxemia during sleep in chronic obstructive pulmonary disease is not a
sleep apnea syndrome. Am.Rev.Respir.Dis. 1983;128:24-9. •
4. Catterall JR, Calverley PM, MacNee W, Warren PM, Shapiro CM, Douglas NJ et al.
Mechanism of transient nocturnal hypoxemia in hypoxic chronic bronchitis and
emphysema. J.Appl.Physiol. 1985;59:1698-703. •
5. Connaughton J J, Catterall JR, Elton RA, Stradling JR, Douglas NJ. Do sleep studies
contribute to the management of patients with severe chronic obstructive pulmonary
disease? Am.Rev.Respir.Dis. 1988;138:341-4. •
6. Fitzpatrick MF, Mackay T, Whyte KF, Allen M, Tarn RC, Dore CJ et al. Nocturnal
desaturation and serum erythropoietin: a study in patients with chronic obstructive
pulmonary disease and in normal subjects. Clin.Sci.(Colch). 1993;84:319-24. •
7. Power JT, Stewart IC, Connaughton JJ, Brash HM, Shapiro CM, Flenley DC et al.
Nocturnal cough in patients with chronic bronchitis and emphysema.
Am.Rev.Respir.Dis. 1984;130:999-1001. •
8. Brezinova V, Catterall JR, Douglas NJ, Calverley PM, Flenley DC. Night sleep of
patients with chronic ventilatory failure and age matched controls: number and
duration of the EEG episodes of intervening wakefulness and drowsiness. Sleep.
1982;5:123-30. •
9. Calverley PM, Brezinova V, Douglas NJ, Catterall JR, Flenley DC. The effect of
oxygenation on sleep quality in chronic bronchitis and emphysema.
Am.Rev.Respir.Dis. 1982;126:206-10. •
10. Connaughton JJ, Douglas NJ, Morgan AD, Shapiro CM, Critchley JA, Pauly N et al.
Almitrine improves oxygenation when both awake and asleep in patients with hypoxia
and carbon dioxide retention caused by chronic bronchitis and emphysema.
Am.Rev.Respir.Dis. 1985; 132:206-10. •
11. Douglas NJ, White DP, Pickett CK, Weil JV, Zwillich CW. Respiration during sleep in
normal man. Thorax 1982;37:840-4. •
12. Douglas NJ, White DP, Weil JV, Pickett CK, Martin RJ, Hudgel DW et al. Hypoxic
ventilatory response decreases during sleep in normal men. Am.Rev.Respir.Dis.
1982;125:286-9. •
13. Douglas NJ, White DP, Weil JV, Pickett CK, Zwillich CW. Hypercapnic ventilatory
response in sleeping adults. Am.Rev.Respir.Dis. 1982;126:758-62. •
14. White DP, Douglas NJ, Pickett CK, Weil JV, Zwillich CW. Hypoxic ventilatory
response during sleep in normal premenopausal women. Am.Rev.Respir.Dis.
1982;126:530-3. •
15. White DP, Douglas NJ, Pickett CK, Zwillich CW, Weil JV. Sleep deprivation and the
control of ventilation. Am.Rev.Respir.Dis. 1983;128:984-6. •
16. Gould GA, Gugger M, Molloy J, Tsara V, Shapiro CM, Douglas NJ. Breathing pattern
and eye movement density during REM sleep in humans. Am.Rev.Respir.Dis.
1988;138:874-7. •
17. Gugger M, Molloy J, Gould GA, Whyte KF, Raab GM, Shapiro CM et al. Ventilatory
and arousal responses to added inspiratory resistance during sleep.
Am.Rev.Respir.Dis. 1989;140:1301-7. •
18. Catterall JR, Douglas NJ, Calverley PM, Brash HM, Brezinova V, Shapiro CM et al.
irregular breathing and hypoxaemia during sleep in chronic stable asthma. Lancet
1982;1:301-4. •
19. Morgan AD, Rhind GB, Connaughton J J, Catterall JR, Shapiro CM, Douglas NJ.
Breathing patterns during sleep in patients with nocturnal asthma. Thorax
1987;42:600-3. •
20. Fitzpatrick MF, Martin K, Fossey E, Shapiro CM, Elton RA, Douglas NJ. Snoring,
asthma and sleep disturbance in Britain: a community- based survey. Eur.Respir.J.
1993;6:531-5. •
21. Catterall JR, Rhind GB, Stewart IC, Whyte KF, Shapiro CM, Douglas NJ. Effect of
sleep deprivation on overnight bronchoconstriction in nocturnal asthma. Thorax
1986;41:676-80. •
22. Catterall JR, Rhind GB, Whyte KF, Shapiro CM, Douglas NJ. Is nocturnal asthma
caused by changes in airway cholinergic activity? Thorax 1988;43:720-4. •
23. Mackay TW, Fitzpatrick MF, Douglas NJ. Non-adrenergic, non-cholinergic nervous
system and overnight airway calibre in asthmatic and normal subjects. Lancet
1991;338:1289-92. •
24. Mackay TW, Hulks G, Douglas NJ. Non-adrenergic, non-cholinergic function in the
human airway. Respir.Med. 1998;92:461-6. •
25. Whyte KF,.Douglas NJ. Posture and nocturnal asthma. Thorax 1989;44:579-81. •
26. Fitzpatrick MF, Mackay T, Walters C, Tai PC, Church MK, Flolgate ST et al.
Circulating histamine and eosinophil cationic protein levels in nocturnal asthma.
Clin. Sci. (Colch). 1992;83:227-32. •
27. Mackay TW, Wallace WA, Flowie SE, Brown PFI, Greening AP, Church MK et al.
Role of inflammation in nocturnal asthma. Thorax 1994;49:257-62. •
28. Fitzpatrick MF, Engleman H, Whyte KF, Deary I J, Shapiro CM, Douglas NJ. Morbidity
in nocturnal asthma: sleep quality and daytime cognitive performance. Thorax
1991;46:569-73. •
29. Fitzpatrick MF, Mackay T, Driver H, Douglas NJ. Salmeterol in nocturnal asthma: a
double blind, placebo controlled trial of a long acting inhaled beta 2 agonist. BMJ.
1990;301:1365-8. •
30. Selby C, Engleman HM, Fitzpatrick MF, Sime PM, Mackay TW, Douglas NJ. Inhaled
salmeterol or oral theophylline in nocturnal asthma? Am.J.Respir.Crit.Care Med.
1997;155:104-8. •
31. Stewart IC, Rhind GB, Power JT, Flenley DC, Douglas NJ. Effect of sustained release
terbutaline on symptoms and sleep quality in patients with nocturnal asthma. Thorax
1987;42:797-800. •
32. Rhind GB, Connaughton J J, McFie J, Douglas NJ , Flenley DC. Sustained release
choline theophyllinate in nocturnal asthma. Br.Med.J.(Clin.Res.Ed). 1985;291:1605-
7. •
33. Morgan AD, Connaughton J J, Catterall JR, Shapiro CM, Douglas NJ, Flenley DC.
Sodium cromoglycate in nocturnal asthma. Thorax 1986;41:39-41. •
34. Catterall JR, Calverley PM, Power JT, Shapiro CM, Douglas NJ, Flenley DC.
Ketotifen and nocturnal asthma. Thorax 1983;38:845-8. •
35. Fitzpatrick MF, Engleman HM, Boellert F, McHardy R, Shapiro CM, Deary IJ et al.
Effect of therapeutic theophylline levels on the sleep quality and daytime cognitive
performance of normal subjects. Am.Rev.Respir.Dis. 1992;145:1355-8. •
36. Catterall JR, Douglas NJ, Calverley PM, Shapiro CM, Flenley DC. Arterial
oxygenation during sleep in patients with right-to-left cardiac or intrapulmonary shunts.
Thorax 1983;38:344-8. •
37. Catterall JR, Calverley PM, Ewing DJ, Shapiro CM, Clarke BF, Douglas NJ.
Breathing, sleep, and diabetic autonomic neuropathy. Diabetes 1984;33:1025-7. •
38. Whyte KF, Allen MB, Jeffrey AA, Gould GA, Douglas NJ. Clinical features of the sleep
apnoea/hypopnoea syndrome. Q.J.Med. 1989;72:659-66. •
39. Marshall I, Maran NJ, Martin S, Jan MA, Rimmington JE, Best JJ et al. Acoustic
reflectometry for airway measurements in man: implementation and validation.
Physiol.Meas. 1993;14:157-69. •
40. Jan MA, Marshall I, Douglas NJ. Effect of posture on upper airway dimensions in
normal human. Am.J.Respir.Crit.Care Med. 1994;149:145-8. •
41. Martin SE, Marshall I, Douglas NJ. The effect of posture on airway caliber with the
sleep- apnea/hypopnea syndrome. Am.J.Respir.Crit.Care Med. 1995;152 :721-4. •
42. Yildirim N, Fitzpatrick MF, Whyte KF, Jalleh R, Wightman AJ, Douglas NJ. The effect
of posture on upper airway dimensions in normal subjects and in patients with the
sleep apnea/hypopnea syndrome. Am.Rev.Respir.Dis. 1991;144:845-7. •
43. Douglas NJ, Jan MA, Yildirim N, Warren PM, Drummond GB. Effect of posture and
breathing route on genioglossal electromyogram activity in normal subjects and in
patients with the sleep apnea/hypopnea syndrome. Am.Rev.Respir.Dis.
1993;148:1341-5. •
44. Mathur R, Mortimore IL, Jan MA, Douglas NJ. Effect of breathing, pressure and
posture on palatoglossal and genioglossal tone. Clin.Sci.(Colch). 1995;89:441-5. •
45. Mortimore IL, Mathur R, Douglas NJ. Effect of posture, route of respiration, and
negative pressure on palatal muscle activity in humans. J.Appi.Physiol. 1995;79:448-
54. •
46. Mortimore IL,.Douglas NJ. Palatopharyngeus has respiratory activity and responds to
negative pressure in sleep apnoeics. Eur.Respir.J. 1996;9:773-8. •
47. Mortimore IL,.Douglas NJ. Palatal muscle EMG response to negative pressure in
awake sleep apneic and control subjects. Am.J.Respir.Crit.Care Med. 1997; 156:867-
73. •
48. Mortimore IL, Kochhar P, Douglas NJ. Effect of chronic continuous positive airway
pressure (CPAP) therapy on upper airway size in patients with sleep
apnoea/hypopnoea syndrome. Thorax 1996;51:190-2. •
49. Martin SE, Mathur R, Marshall I, Douglas NJ. The effect of age, sex, obesity and
posture on upper airway size. Eur.Respir.J. 1997;10:2087-90. •
50. Whittle AT, Marshall I, Mortimore IL, Wraith PK, Sellar RJ, Douglas NJ. Neck soft
tissue and fat distribution: comparison between normal men and women by magnetic
resonance imaging. Thorax 1999;54:323-8. •
51. Thurnheer R, Wraith PK, Douglas NJ. Influence of age and gender on upper airway
resistance in NREM and REM sleep. J.Appl.Physiol. 2001;90:981-8. •
52. Catterall JR, Calverley PM, Shapiro CM, Flenley DC, Douglas NJ. Breathing and
oxygenation during sleep are similar in normal men and normal women.
Am.Rev.Respir.Dis. 1985;132:86-8. •
53. Mathur R,.Douglas NJ. Frequency of EEG arousals from nocturnal sleep in normal
subjects. Sleep. 1995;18:330-3. •
54. Mortimore IL, Fiddes P, Stephens S, Douglas NJ. Tongue protrusion force and
fatiguability in male and female subjects. Eur.Respir.J. 1999;14:191-5. •
55. Mortimore IL, Bennett SP, Douglas NJ. Tongue protrusion strength and fatiguability:
relationship to apnoea/hypopnoea index and age. J Sleep Res 2000;9:389-93. •
56. Mortimore IL, Marshall I, Wraith PK, Sellar RJ, Douglas NJ. Neck and total body fat
deposition in nonobese and obese patients with sleep apnea compared with that in
control subjects. Am.J.Respir.Crit.Care Med. 1998;157:280-3. •
57. Brander PE, Mortimore IL, Douglas NJ. Effect of obesity and erect/supine posture on
lateral cephalometry: relationship to sleep-disordered breathing. Eur.Respir.J.
1999;13:398-402. •
58. Douglas NJ, Luke M, Mathur R. Is the sleep apnoea/hypopnoea syndrome inherited?
Thorax 1993;48:719-21. •
59. Mathur R,.Douglas NJ. Family studies in patients with the sleep apnea-hypopnea
syndrome. Ann.Intern.Med. 1995;122:174-8. •
60. Jalleh R, Fitzpatrick MF, Mathur R, Douglas NJ. Do patients with the sleep
apnea/hypopnea syndrome drink more alcohol? Sleep. 1992;15:319-21. •
61. Cheshire K, Engleman H, Deary I, Shapiro C, Douglas NJ. Factors impairing daytime
performance in patients with sleep apnea/hypopnea syndrome. Arch.Intern.Med.
1992;152:538-41. •
62. Kingshott RN, Engleman HM, Deary IJ, Douglas NJ. Does arousal frequency predict
daytime function? Eur.Respir.J. 1998;12:1264-70. •
63. Kingshott RN, Vennelle M, Hoy CJ, Engleman HM , Deary IJ, Douglas NJ. Predictors
of improvements in daytime function outcomes with CPAP therapy. Am.J.Respir.Crlt
Care Med. 2000;161:866-71. •
64. Barbe F, Mayoralas LR, Duran J, Masa JF, Maimo A, Montserrat JM et at. Treatment
with continuous positive airway pressure is not effective in patients with sleep apnea
but no daytime sleepiness, a randomized, controlled trial. Ann Intern.Med
2001;134:1015-23. •
65. Engleman HM, Cheshire KE, Deary IJ, Douglas NJ. Daytime sleepiness, cognitive
performance and mood after continuous positive airway pressure for the sleep
apnoea/hypopnoea syndrome. Thorax 1993;48:911-4. •
66. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of continuous positive airway
pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet
1994;343:572-5. •
67. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of CPAP therapy on daytime
function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax
1997;52:114-9. •
68. Engleman HM, Martin SE, Kingshott RN, Mackay TW, Deary IJ, Douglas NJ.
Randomised placebo controlled trial of daytime function after continuous positive
airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax
1998;53:341-5. •
69. Martin SE, Engleman HM, Deary IJ, Douglas NJ. The effect of sleep fragmentation on
daytime function. Am.J.Respir.Crit.Care Med. 1996;153:1328-32. •
70. Martin SE, Wraith PK, Deary IJ, Douglas NJ. The effect of nonvisible sleep
fragmentation on daytime function. Am.J.Respir.Crlt.Care Med. 1997;155:1596-601. •
71. Martin SE, Brander PE, Deary IJ, Douglas NJ. The effect of clustered versus regular
sleep fragmentation on daytime function. J.Sleep Res. 1999;8:305-11. •
72. Kingshott RN, Cosway RJ, Deary IJ, Douglas NJ . The effect of sleep fragmentation
on cognitive processing using computerized topographic brain mapping. J Sleep Res
2000;9:353-7. •
73. Kingshott R, Douglas N, Deary I. Mokken scaling of the Epworth Sleepiness Scale
items in patients with the sleep apnoea/hypopnoea syndrome. J.Sleep.Res.
1998;7:293-4. •
74. Kingshott RN, Sime PJ, Engleman HM, Douglas NJ. Self assessment of daytime
sleepiness: patient versus partner. Thorax 1995;50 :994-5. •
75. Kingshott RN,.Douglas NJ. The effect of in laboratory polysomnography on sleep and
objective daytime sleepiness. Sleep 2000;23:1109-13.
76. Engleman HM, Hirst WS, Douglas NJ. Under reportin • g of sleepiness and driving
impairment in patients with sleep apnoea/hypopnoea syndrome. J.Sleep.Res.
1997;6:272-5. •
77. Engleman HM, Asgari-Jirhandeh N, McLeod AL, Ramsay CF, Deary IJ, Douglas NJ.
Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest
1996;109:1470-6. •
78. Engleman HM, Gough K, Martin SE, Kingshott RN, Padfield PL, Douglas NJ.
Ambulatory blood pressure on and off continuous positive airway pressure therapy for
the sleep apnea/hypopnea syndrome: effects in "non- dippers". Sleep. 1996; 19:378-
81. •
79. Faccenda JF, Mackay TW, Boon NA, Douglas NJ. Randomized Placebo-controlled
Trial of Continuous Positive Airway Pressure on Blood Pressure in the Sleep ApneaFlypopnea Syndrome. Am.J.Respir.Crit Care Med. 2001;163:344-8. •
80. Zwillich C, Devlin T, White D, Douglas N, Weil J, Martin R. Bradycardia during sleep
apnea. Characteristics and mechanism. J.Clin.Invest. 1982;69:1286-92. •
81. Whyte KF,.Douglas NJ. Peripheral edema in the sleep apnea/hypopnea syndrome.
Sleep. 1991;14:354-6. •
82. Mathur R,.Douglas NJ. Relation between sudden infant death syndrome and adult
sleep apnoea/hypopnoea syndrome. Lancet 1994;344:819-20. •
83. Rees K, Wright A, Keeling JW, Douglas NJ. Facial structure in the sudden infant
death syndrome: case- control study. BMJ. 1998;317:179-80. •
84. Mackay TW, Fitzpatrick MF, Freestone S, Lee MR, Douglas NJ. Atrial natriuretic
peptide levels in the sleep apnoea/hypopnoea syndrome. Thorax 1994;49:920-1. •
85. Gould GA, Whyte KF, Rhind GB, Airlie MA, Catterall JR, Shapiro CM et al. The sleep
hypopnea syndrome. Am.Rev.Respir.Dis. 1988;137:895-8. •
86. Whyte KF, Gugger M, Gould GA, Molloy J, Wraith PK, Douglas NJ. Accuracy of
respiratory inductive plethysmograph in measuring tidal volume during sleep.
J.Appl. Physiol. 1991; 71:1866-71. •
87. Whyte KF, Allen MB, Fitzpatrick MF, Douglas NJ. Accuracy and significance of
scoring hypopneas. Sleep. 1992;15:257-60. •
88. Engleman HM, Kingshott RN, Wraith PK, Mackay TW, Deary IJ, Douglas NJ.
Randomized placebo-controlled crossover trial of continuous positive airway pressure
for mild sleep Apnea/Hypopnea syndrome. Am.J.Respir.Crit Care Med.
1999;159:461-7. •
89. Martin SE, Engleman HM, Kingshott RN, Douglas NJ. Microarousals in patients with
sleep apnoea/hypopnoea syndrome. J.Sleep.Res. 1997;6:276-80. •
90. Rees K, Kingshott RN, Wraith PK, Douglas NJ . Frequency and significance of
increased upper airway resistance during sleep. Am.J.Respir.Crit Care Med
2000;162:1210-4. •
91. Douglas NJ, Thomas S, Jan MA. Clinical value of polysomnography. Lancet
1992;339:347-50. •
92. Tweeddale PM,.Douglas NJ. Evaluation of Biox IIA ear oximeter. Thorax
1985;40:825-7. •
93. Biernacka H,.Douglas NJ. Evaluation of a computerised polysomnography system.
Thorax 1993;48:280-3. •
94. Bradley PA, Mortimore IL, Douglas NJ. Comparison of polysomnography with
ResCare Autoset in the diagnosis of the sleep apnoea/hypopnoea syndrome. Thorax
1995;50:1201-3. •
95. Whittle AT, Finch SP, Mortimore IL, Mackay TW, Douglas NJ. Use of home sleep
studies for diagnosis of the sleep apnoea/hypopnoea syndrome. Thorax
1997;52:1068-73. •
96. Rees K, Wraith PK, Berthon-Jones M, Douglas NJ. Detection of apnoeas,
hypopnoeas and arousals by the AutoSet in the sleep apnoea/hypopnoea syndrome.
Eur.Respir.J. 1998;12:764-9. •
97. McArdle N, Grove A, Devereux G, Mackay-Brown L, Mackay T, Douglas NJ. Splitnight versus full-night studies for sleep apnoea/hypopnoea syndrome. Eur.Respir.J.
2000;15:670-5. •
98. Whittle AT,.Douglas NJ. Does the physiological success of CPAP titration predict
clinical success? J Sleep Res. 2000;9:201-6. •
99. McFadyen TA, Espie CA, McArdle N, Douglas NJ , Engleman HM. Controlled,
prospective trial of psychosocial function before and after continuous positive airway
pressure therapy. Eur.Respir.J 2001;18:996-1002. •
100. Douglas NJ, Engleman HM, Faccenda JF, McArdle N. The science of designing
ethical CPAP trials. Am J Respir.Crit Care Med 2002;165:132-4. •
101. McArdle N,.Douglas NJ. Effect of Continuous Positive Airway Pressure on Sleep
Architecture in the Sleep Apnea-Hypopnea Syndrome. A randomized controlled trial.
Am J Respir.Crit Care Med 2001; 164:1459-63. •
102
Argyres-Douglas theories and S-duality
No full textThis article is distributed under the terms of the Creative Commons
Attribution License (CC-BY 4.0), which permits any use, distribution and reproduction in any medium, provided the original author(s) and source are creditedM.B. and T.N. are partly supported by the U.S. Department of Energy under grants DOE-SC0010008, DOE-ARRA-SC0003883, and DOE-DE-SC0007897.
This research was supported in part by the National Science Foundation under Grant No.
NSF PHY11-25915. S.G. is partially supported by the ERC Advanced Grant “SyDuGraM”,
by FNRS-Belgium (convention FRFC PDR T.1025.14 and convention IISN 4.4514.08) and by the “Communaut´e Francaise de Belgique” through the ARC progra
Using attribute slicing to refactor large classes
No full textIt can often be the case in object-oriented programming that classes bloat, particularly if the represent an ill-formed abstraction. A poorly formed class tends to be formed from disjoint sets of methods and attributes. This can result in a loss of cohesion within the class. Slicing attributes can be used to identify and make explicit the relationships between attributes and the methods that refer to them. This can be a useful tool for identifying code smells and ultimately refactoring. Attribute slicing can also be used to examine the relationships between attributes, as is the case in decomposition slicing. This paper introduces attribute slicing in the context of refactoring bloated classes
Letter from Douglas M. Todd, Assistant Project Manager, Heart Mountain Relocation Project, to Mr. Shoji Nagumo, September 20, 1943
No full textLetter to Shoji Nagumo regarding his appointment as Manager for Block 12 at Heart Mountain incarceration camp.The Japanese American Archival Collection documents the people, places, and daily life of Japanese Americans, primarily those who lived in the once thriving community of pre-war Florin in the Sacramento region, as well as the conditions in American incarceration camps during World War II. The approximately 7,000 original items include personal and official letters, photographs, diaries, arts and crafts, newsletters, textiles, camps artifacts, yearbooks and other publications
An Annotated Bibliography of the Douglas-fir Beetle (Dendroctonus pseudotsugae Hopkins)
No full textAnnotates contents of the 263 published references of the Douglas-fir bark beetle through 1977. Includes only publications of major importance directly related to the Douglas-fir beetle. References are indexed by author and subject. Updates USDA Forest Service General Technical Report INT-8 1973
- …
